Amcor announces breakthrough healthcare lidding technology for compound products

0
276
Source: Amcor

• Produced in collaboration with a leading healthcare company

• Ideal for combination healthcare products, so as devices with an Active Pharmaceutical Component

• Technology leverages Amcor’s best-in-class discovery and R&D capabilities

Amcor, a global leader in producing and presenting a diverse offering of responsible packaging solutions, declared the launch of a restrictive healthcare lidding technology appropriate for combination products consisting of two or more regulated components (device, drug, or drug, or biologic).

This most advanced innovation from Amcor is based on patented inert film development and laminate design. It presents a lidding solution that can withstand heat sterilization, the method of preserving and sterilizing items while preventing drug uptake into the packaging. The packaging solution is perfect for combining healthcare products and devices with an Active Pharmaceutical Ingredient (API) that forms the basis of medicine.

It assures machinability, integrity after sterilization, as well as a convenient peel availability for patients. The characteristics of the new product complement Amcor’s current healthcare portfolio, which ranges from lidding for demanding sterilization environments to great barrier overwraps protecting eye droppers and medications for the eye.

Amcor cooperated with Johnson & Johnson Vision over many years to develop the lidding technology for contact lenses. Every company contributed specific skills and perspectives, notably Amcor’s expertise with film extrusion, lamination, and conversion for healthcare, and J&J Vision’s expertise on ophthalmic device packaging requirements.

Peter Konieczny, Amcor’s Chief Commercial Officer, said: “We are beginning together industry-leading innovation and close customer connections to improve the packaging solutions of the future. This next-generation healthcare lidding technology means we are starting a world of possibilities for products applying effective pharma ingredients. We look ahead to extending this differentiated lidding technology to different combination products in the future.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here